All Stories

Merck granted Rob Davis a pay boost to $23.2M, inching CEO’s 2024 compensation closer to large pharma peers

Merck has handed out another hefty raise to CEO Rob Davis, boosting his compensation by 13% to $23.2 million in 2024, according to the company’s 2025 proxy statement.

Apr 10, 2025 - 18:00
 0
Merck granted Rob Davis a pay boost to $23.2M, inching CEO’s 2024 compensation closer to large pharma peers
Merck has handed out another hefty raise to CEO Rob Davis, boosting his compensation by 13% to $23.2 million in 2024, according to the company’s 2025 proxy statement.
Read More

Tags:

Previous Article

Freight orders surge on Trump tariffs trade whipsaw: 'The ships are filling up'

Next Article

Pentagon chief says US could ‘revive’ Panama bases

Related Posts

After $2.2B Zantac settlement, GSK now faces investor lawsuit over the heartburn medication

After $2.2B Zantac settlement, GSK now faces investor l...

Feb 9, 2025  0

Pfizer outlines Talzenna's survival benefit in bid for broad prostate cancer approval

Pfizer outlines Talzenna's survival benefit in bid for ...

Feb 13, 2025  0

In patent clash over injectable Keytruda, Merck and Halozyme dig in for a fight

In patent clash over injectable Keytruda, Merck and Hal...

Mar 6, 2025  0